Analytical Overview: Black Diamond Therapeutics Inc (BDTX)’s Ratios Tell a Financial Story

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

As of close of business last night, Black Diamond Therapeutics Inc’s stock clocked out at $2.50, down -5.30% from its previous closing price of $2.64. In other words, the price has decreased by -$5.30 from its previous closing price. On the day, 0.55 million shares were traded. BDTX stock price reached its highest trading level at $2.655 during the session, while it also had its lowest trading level at $2.425.

Ratios:

To gain a deeper understanding of BDTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.55 and its Current Ratio is at 5.55. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.20.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $20.

Stifel Upgraded its Hold to Buy on June 30, 2023, whereas the target price for the stock was revised from $2 to $10.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 28 ’24 when Versant Venture Capital VI, L. sold 221,600 shares for $6.32 per share. The transaction valued at 1,400,556 led to the insider holds 3,726,341 shares of the business.

David Epstein bought 50,000 shares of BDTX for $310,000 on Jul 31 ’24. On Jul 26 ’24, another insider, David Epstein, who serves as the Former Employee of the company, bought 50,000 shares for $6.20 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 141462752 and an Enterprise Value of 51779656.

Stock Price History:

Over the past 52 weeks, BDTX has reached a high of $7.66, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is -13.35%, while the 200-Day Moving Average is calculated to be -46.45%.

Shares Statistics:

It appears that BDTX traded 1.18M shares on average per day over the past three months and 483190 shares per day over the past ten days. A total of 56.52M shares are outstanding, with a floating share count of 42.93M. Insiders hold about 24.13% of the company’s shares, while institutions hold 75.31% stake in the company. Shares short for BDTX as of 1732838400 were 6125851 with a Short Ratio of 5.20, compared to 1730332800 on 6328308. Therefore, it implies a Short% of Shares Outstanding of 6125851 and a Short% of Float of 18.22.

Most Popular